Investors considering a purchase of Momenta Pharmaceuticals Inc (NASD: MNTA) stock, but tentative about paying the going market price of $14.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2014 put at the $11 strike, which has a bid at the time of this writing of $1.05. Collecting that bid as the premium represents a 9.6% return against the $11 commitment, or a 15.7% annualized ra...
Investors considering a purchase of Momenta Pharmaceuticals Inc (NASD: MNTA) stock, but tentative about paying the going market price of $14.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2014 put at the $11 strike, which has a bid at the time of this writing of $1.05. Collecting that bid as the premium represents a 9.6% return against the $11 commitment, or a 15.7% annualized ra...
Share this Article
Recommended